LGALS9 and glioblastoma: Besides, extracellular vesicles from GBM stem cells, like LGALS9, can hamper DC antigen presentation.79 Furthermore, tumor-infiltrating DCs may elevate the presentation of immune-inhibitory molecules like PD-L1.80 Monocytes in the TME can diminish DC antigen presentation through paracrine mechanisms.81